<i>In Situ</i> Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy-Reference-Cited by-同舟云学术

In Situ Sprayed Nanovaccine Suppressing Exosomal PD-L1 by Golgi Apparatus Disorganization for Postsurgical Melanoma Immunotherapy

Published:2023-05-22 Issue:11 Volume:17 Page:10637-10650
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Ye Hao¹²^ORCID,Wang Kaiyuan¹^ORCID,Zhao Jian¹,Lu Qi¹,Wang Menglin³,Sun Bingjun¹,Shen Yang⁴^ORCID,Liu Hongchen⁵,Pané Salvador²^ORCID,Chen Xiang-Zhong²^ORCID,He Zhonggui¹,Sun Jin¹^ORCID

Affiliation:

1. Department of Pharmaceutics, Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, Shenyang Liaoning 110016, P. R. China

2. Multi-Scale Robotics Lab (MSRL), Institute of Robotics & Intelligent Systems (IRIS), ETH Zürich, Zürich 8092, Switzerland

3. Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

4. Institute of Food, Nutrition and Health, ETH Zürich, Schmelzbergstrasse 7, Zürich 8092, Switzerland

5. State Key Laboratory of Pulp and Paper Engineering, South China University of Technology, Guangzhou 510641, P. R. China

Funder

Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung

Liaoning Revitalization Talents Program

National Natural Science Foundation of China

State Key Laboratory on Integrated Optoelectronics

Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.3c01733

Reference57 articles.

1. Metastasis as an evolutionary process

2. In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment

3. In situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy

4. Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma

5. Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tectorigenin Inhibits Glycolysis-induced Cell Growth and Proliferation by Modulating LncRNA CCAT2/miR-145 Pathway in Colorectal Cancer;Current Cancer Drug Targets;2024-10

2. Exosome-based nanoparticles and cancer immunotherapy;Biomedicine & Pharmacotherapy;2024-10

3. Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: Current strategies and beyond;Advanced Drug Delivery Reviews;2024-09

4. Advancements in melanoma immunotherapy: the emergence of Extracellular Vesicle Vaccines;Cell Death Discovery;2024-08-23

5. Simplified Synthesis of Dicoumarol-Based Copolyester for Anticancer Drug Delivery;Chemistry;2024-08-22